JCX-8-23 (May 09, 2023)
Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
Related Publications
-
JCX-10-25 (February 12, 2025)
Income And Payroll Tax Offsets To Changes In Excise Tax Revenues For 2025–2035
view details -
JCX-1-25 (January 09, 2025)
List Of Expiring Federal Tax Provisions 2024-2034
view details -
JCX-48-24 (December 11, 2024)
Estimates Of Federal Tax Expenditures For Fiscal Years 2024-2028
view details